Edgar Francisco Carrizales-Sepúlveda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Edgar Francisco Carrizales-Sepúlveda has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Raymundo Vera-Pineda
Internal Medicine Department, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico
16 shared publications Ramiro Flores-Ramírez
15 shared publications- Alejandro Ordaz-Farías
Echocardiography Laboratory, Cardiology Service, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico
12 shared publications Raymundo Vera-Pineda
Heart Failure Unit, Cardiology Service, Hospital Universitario "Dr. José E. González," Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
8 shared publicationsRaúl Alberto Jiménez-Castillo
Internal Medicine Department, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico
6 shared publications- Ramiro Flores-Ramírez
Cardiology Service, Hospital Universitario “Dr. José E. González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico
5 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (36)
Chylopericardium and Plastic Bronchitis From Thoracic Duct Dysfunction
- 28 July 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (36)
Open AccessChylopericardium and Plastic Bronchitis From Thoracic Duct Dysfunction
- 13 October 2025
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 27 (12) , 3432-3433
Sodium Chloride Versus Glucose Solute as a Volume Replacement Therapy for More Effective Decongestion in Acute Heart Failure: It is Probably just the Chloride! Letter Regarding the Article ‘Sodium Chloride Versus Glucose Solute as a Volume Replacement Therapy for More Effective Decongestion in Acute Heart Failure (SOLVRED-AHF): A Prospective, Randomized, Mechanistic Study’
- 13 October 2025
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 27 (12) , 3432-3433
Sodium Chloride Versus Glucose Solute as a Volume Replacement Therapy for More Effective Decongestion in Acute Heart Failure: It is Probably just the Chloride! Letter Regarding the Article ‘Sodium Chloride Versus Glucose Solute as a Volume Replacement Therapy for More Effective Decongestion in Acute Heart Failure (SOLVRED-AHF): A Prospective, Randomized, Mechanistic Study’
- Open Access
- 2 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (5) , ytaf197
When beats are hard to crack: electrical storm in a patient with severe myocardial calcification
- 2 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (5) , ytaf197
Open AccessWhen beats are hard to crack: electrical storm in a patient with severe myocardial calcification
- 29 April 2025
- Published by Wiley in Echocardiography
- Vol. 42 (5) , e70174
A Deeper Dive Into the Myocardium for the Detection of Cancer Therapy‐Related Cardiac Dysfunction: Radiomics in Cardio‐Oncology
- 29 April 2025
- Published by Wiley in Echocardiography
- Vol. 42 (5) , e70174
A Deeper Dive Into the Myocardium for the Detection of Cancer Therapy‐Related Cardiac Dysfunction: Radiomics in Cardio‐Oncology
- Open Access
- 3 April 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (7) , 103498
Incidental Discovery of Dystrophic Myocardial Calcification
- 3 April 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (7) , 103498
Open AccessIncidental Discovery of Dystrophic Myocardial Calcification
- 2 December 2024
- Published by Elsevier in JACC: Heart Failure
- Vol. 12 (12) , 2123-2124
Choosing the Appropriate Combination of Diuretics for Patients With Heart Failure and Congestion
- 2 December 2024
- Published by Elsevier in JACC: Heart Failure
- Vol. 12 (12) , 2123-2124
Choosing the Appropriate Combination of Diuretics for Patients With Heart Failure and Congestion
- Open Access
- 28 October 2024
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 23 (1) , 1-13
Comprehensive echocardiographic and biomarker assessment of patients with diabetic ketoacidosis
Systemic stress, inflammation, and hydroelectrolytic and acid‒base abnormalities observed during diabetic ketoacidosis (DKA) can cause changes in the heart and even induce cardiovascular damage. We aimed to evaluate the structure and function of the heart during and after a DKA episode via echocardiography and biomarker assessment. We performed a transthoracic echocardiogram (TTE) in subjects with an episode of DKA in the first 4–6 h of treatment. We evaluated left ventricular wall thickness, diameters and volumes, as well as systolic and diastolic function using tissue Doppler imaging, pulsed wave Doppler and left ventricular ejection fraction (LVEF). Left ventricular function was also assessed with global longitudinal strain (GLS). We obtained cardiac troponin levels in the first 24 h after admission. A second TTE was performed following the same protocol 6–12 h after the resolution of the DKA episode. We included a total of 20 subjects. The mean age was 33 ± 13.6 years; 70% were female, and 70% had type 1 DM. 75% of the patients experienced severe episodes, and the rest experienced moderate episodes. Left ventricular isovolumetric contraction and ejection time were significantly shorter during DKA and prolonged after the resolution of the episodes (47.6 ± 9.9 vs. 62.2 ± 14.1, p = < 0.001) and (218.6 ± 37.9 vs. 265.06 ± 34.7). The isovolumetric relaxation time was also shorter during DKA, (41.72 ± 8.29 vs. 59.32 ± 17.98, p = < 0.001). Volumes and diameters of the left ventricle increased significantly after DKA resolution. We found no difference between LVEF or GLS during and after DKA resolution. 20% of the participants had troponin elevations, half of whom had moderate episodes and half of whom had severe episodes. 35% had LV dysfunction, 28.5% both in GLS and LVEF. 28.5% occurred after DKA resolution, with alterations in GLS. Diabetic ketoacidosis induces changes in the structure and function of the heart, which are mostly transient, reflect the presence of a hyperdynamic state and resolve after the resolution of the episode. Some subjects present with evidence of myocardial injury with elevated cardiac troponin and left ventricular dysfunction. Icons in the graphical abstract are made by Freepik from www.flaticon.com .
- 28 October 2024
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 23 (1) , 1-13
Open AccessComprehensive echocardiographic and biomarker assessment of patients with diabetic ketoacidosis
Systemic stress, inflammation, and hydroelectrolytic and acid‒base abnormalities observed during diabetic ketoacidosis (DKA) can cause changes in the heart and even induce cardiovascular damage. We aimed to evaluate the structure and function of the heart during and after a DKA episode via echocardiography and biomarker assessment. We performed a transthoracic echocardiogram (TTE) in subjects with an episode of DKA in the first 4–6 h of treatment. We evaluated left ventricular wall thickness, diameters and volumes, as well as systolic and diastolic function using tissue Doppler imaging, pulsed wave Doppler and left ventricular ejection fraction (LVEF). Left ventricular function was also assessed with global longitudinal strain (GLS). We obtained cardiac troponin levels in the first 24 h after admission. A second TTE was performed following the same protocol 6–12 h after the resolution of the DKA episode. We included a total of 20 subjects. The mean age was 33 ± 13.6 years; 70% were female, and 70% had type 1 DM. 75% of the patients experienced severe episodes, and the rest experienced moderate episodes. Left ventricular isovolumetric contraction and ejection time were significantly shorter during DKA and prolonged after the resolution of the episodes (47.6 ± 9.9 vs. 62.2 ± 14.1, p = < 0.001) and (218.6 ± 37.9 vs. 265.06 ± 34.7). The isovolumetric relaxation time was also shorter during DKA, (41.72 ± 8.29 vs. 59.32 ± 17.98, p = < 0.001). Volumes and diameters of the left ventricle increased significantly after DKA resolution. We found no difference between LVEF or GLS during and after DKA resolution. 20% of the participants had troponin elevations, half of whom had moderate episodes and half of whom had severe episodes. 35% had LV dysfunction, 28.5% both in GLS and LVEF. 28.5% occurred after DKA resolution, with alterations in GLS. Diabetic ketoacidosis induces changes in the structure and function of the heart, which are mostly transient, reflect the presence of a hyperdynamic state and resolve after the resolution of the episode. Some subjects present with evidence of myocardial injury with elevated cardiac troponin and left ventricular dysfunction. Icons in the graphical abstract are made by Freepik from www.flaticon.com .
- Open Access
- 6 March 2024
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 10, e03
Initiation and Up-titration of Guideline-directed Medical Therapy for Patients with Heart Failure: Better, Faster, Stronger!
Treatment for heart failure has experienced a major revolution in recent years, and current evidence shows that a combination of four medications (angiotensin receptor-neprilysin inhibitors + β-blockers + mineralocorticoid receptor antagonists + sodium−glucose cotransporter 2 inhibitors) offer the greatest benefit to our patients with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality. Unfortunately, despite their proven benefits, the implementation of these therapies is still low. Clinical inertia, and unfounded fear of using these drugs might contribute to this. Recently, evidence from randomised clinical trials has shown that intensive implementation of these therapies in patients with heart failure is safe and effective. In this review, we attempt to tackle some of these misconceptions/fears regarding medical therapy for heart failure and discuss the available evidence showing the best strategies for implementation of these therapies.
- 6 March 2024
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 10, e03
Open AccessInitiation and Up-titration of Guideline-directed Medical Therapy for Patients with Heart Failure: Better, Faster, Stronger!
Treatment for heart failure has experienced a major revolution in recent years, and current evidence shows that a combination of four medications (angiotensin receptor-neprilysin inhibitors + β-blockers + mineralocorticoid receptor antagonists + sodium−glucose cotransporter 2 inhibitors) offer the greatest benefit to our patients with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality. Unfortunately, despite their proven benefits, the implementation of these therapies is still low. Clinical inertia, and unfounded fear of using these drugs might contribute to this. Recently, evidence from randomised clinical trials has shown that intensive implementation of these therapies in patients with heart failure is safe and effective. In this review, we attempt to tackle some of these misconceptions/fears regarding medical therapy for heart failure and discuss the available evidence showing the best strategies for implementation of these therapies.
- Open Access
- 5 October 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 7 (10) , ytad493
Failing in reverse: a case report of reverse Takotsubo syndrome complicating peripartum
Background: Pregnancy and the peripartum are states of stress for the cardiovascular system. These conditions can trigger different cardiomyopathies. Among these, Takotsubo cardiomyopathy (TC) has been increasingly recognized as a cause of transient left ventricular dysfunction associated with pregnancy. Case summary: We present the case of a 31-year-old multiparous woman with an unusual variant of TC after caesarean delivery. Discussion: Peripartum cardiomyopathy and TC are particularly interesting differential diagnoses for new systolic dysfunction in pregnancy. Some features, such as the time of presentation, regional or diffuse wall motion abnormalities, evolution, and biomarkers, can guide the clinician to the right diagnosis.
- 5 October 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 7 (10) , ytad493
Open AccessFailing in reverse: a case report of reverse Takotsubo syndrome complicating peripartum
Background: Pregnancy and the peripartum are states of stress for the cardiovascular system. These conditions can trigger different cardiomyopathies. Among these, Takotsubo cardiomyopathy (TC) has been increasingly recognized as a cause of transient left ventricular dysfunction associated with pregnancy. Case summary: We present the case of a 31-year-old multiparous woman with an unusual variant of TC after caesarean delivery. Discussion: Peripartum cardiomyopathy and TC are particularly interesting differential diagnoses for new systolic dysfunction in pregnancy. Some features, such as the time of presentation, regional or diffuse wall motion abnormalities, evolution, and biomarkers, can guide the clinician to the right diagnosis.
- 6 April 2023
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 34 (4) , 276-277
Editorial commentary: The complex interplay between periodontal and cardiovascular disease: The eyes to know the soul, the mouth to see the heart
- 6 April 2023
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 34 (4) , 276-277
Editorial commentary: The complex interplay between periodontal and cardiovascular disease: The eyes to know the soul, the mouth to see the heart